文献速递肿瘤 PET/CT

68Ga-PSMA、68Ga-FAPI与18F-FDG PET/CT显像的前列腺黏液腺癌特征

The Characteristics of Prostate Mucinous Adenocarcinoma Visualized by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2025-06-05

本文报道一例62岁经活检证实为前列腺黏液腺癌的男性患者,行MRI及多示踪剂PET/CT检查。PET/CT显示前列腺病灶对68Ga-PSMA和68Ga-FAPI呈中度摄取,而对18F-FDG摄取显著增高,全身其他部位未见异常示踪剂摄取。多示踪剂PET/CT表现提示18F-FDG可能是原发性前列腺黏液腺癌全身评估更合适的放射性示踪剂。

要点

  • 62岁男性前列腺黏液腺癌患者行68Ga-PSMA、68Ga-FAPI和18F-FDG PET/CT多示踪剂显像。
  • 前列腺病灶对68Ga-PSMA和68Ga-FAPI呈中度摄取,对18F-FDG摄取显著增高。
  • 全身其他部位未见异常示踪剂摄取,提示18F-FDG可能更适合全身评估。

核心结论

  • 多示踪剂PET/CT表现提示18F-FDG可能是原发性前列腺黏液腺癌全身评估更合适的放射性示踪剂。

研究设计与样本

  • 个案报道:一例62岁经活检证实为前列腺黏液腺癌的男性患者,行MRI及68Ga-PSMA、68Ga-FAPI和18F-FDG多示踪剂PET/CT检查。

主要发现

  • PET/CT显示前列腺病灶对68Ga-PSMA和68Ga-FAPI呈中度摄取,对18F-FDG摄取显著增高。
  • 全身其他部位未见异常示踪剂摄取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary prostate mucinous adenocarcinoma is an exceedingly rare entity with distinct imaging characteristics. We report the case of a 62-year-old man with biopsy-proven prostate mucinous adenocarcinoma. The patient underwent MRI and multi-tracer PET/CT. PET/CT images demonstrated the prostate lesion with moderate uptake of 68 Ga-PSMA and 68 Ga-FAPI, yet significantly high 18 F-FDG uptake. No abnormal radiotracers' uptake was observed elsewhere in the body. Multi-tracer PET/CT findings suggest that 18 F-FDG may be a more suitable radiotracer for the systemic assessment of primary prostate mucinous adenocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sun Z, Jiang X, Fu G, et al. The Characteristics of Prostate Mucinous Adenocarcinoma Visualized by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT. Clin Nucl Med. 2025. PMID: 40472312. doi:10.1097/RLU.0000000000006004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。